Page last updated: 2024-08-22

trimethaphan and Cardiovascular Diseases

trimethaphan has been researched along with Cardiovascular Diseases in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
TEWFIK, GI; WELLS, BG1
Jones, PP; Jordan, J; Keisling, GA; Quaife, RA; Seals, DR; Shannon, JR; Shapiro, LF1

Other Studies

2 other study(ies) available for trimethaphan and Cardiovascular Diseases

ArticleYear
The use of arfonad for the alleviation of cardio-vascular stress following electro-convulsive therapy.
    The Journal of mental science, 1957, Volume: 103, Issue:432

    Topics: Autonomic Agents; Cardiovascular Diseases; Convulsive Therapy; Electroconvulsive Therapy; Trimethaphan

1957
Altered autonomic support of arterial blood pressure with age in healthy men.
    Circulation, 2001, Nov-13, Volume: 104, Issue:20

    Topics: Adrenergic alpha-Agonists; Adult; Aged; Aging; Autonomic Nervous System; Blood Pressure; Cardiac Output; Cardiovascular Diseases; Ganglia, Autonomic; Ganglionic Blockers; Heart; Heart Rate; Humans; Men; Phenylephrine; Trimethaphan

2001